Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

AKTS FY 2022 Earnings — Aktis Oncology, Inc. Revenue & Financial Results | Market Cap Arena

AKTSAktis Oncology, Inc.

$1B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$20M

Net Income

-$18M

EPS (Diluted)

$0.00

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$20M

Stock-Based Comp.

$698,000

Balance Sheet

Total Assets

$138M

Total Liabilities

$158M

Stockholders' Equity

-$19M

Cash & Equivalents

$129M

← FY 2023 All Quarters